Evidence map›Paper›PMID 37555097›Full record

ReviewRSC advances2023

A comprehensive review of bioleaching optimization by statistical approaches: recycling mechanisms, factors affecting, challenges, and sustainability.

Tannaz Naseri, Vahid Beiki, Seyyed Mohammad Mousavi, Sebastien Farnaud

Abstract readReview
In one paragraph

Review in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tannaz NaseriBiotechnology Group, Chemical Engineering Department, Tarbiat Modares University Tehran Iran Mousavi_m@modares.ac.ir +98-21-82884931 +98-21-82884917.ORCID https://orcid.org/0000-0001-6289-5637
Vahid BeikiBiotechnology Group, Chemical Engineering Department, Tarbiat Modares University Tehran Iran Mousavi_m@modares.ac.ir +98-21-82884931 +98-21-82884917.
Seyyed Mohammad MousaviBiotechnology Group, Chemical Engineering Department, Tarbiat Modares University Tehran Iran Mousavi_m@modares.ac.ir +98-21-82884931 +98-21-82884917.ORCID https://orcid.org/0000-0002-0381-8292
Sebastien FarnaudCSELS, Faculty of Health & Life Sciences, Coventry University Coventry UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A serious environmental problem is associated with the accumulation of solid waste on the Earth. Researchers are encouraged to find an efficient and sustainable method to recover highly profitable heavy metals and precious and base metals. Bioleaching is a green method of recovering valuable metals from solid waste. Optimizing the variables and conditions of the bioleaching process is crucial to achieving maximum metal recovery most cost-effectively. The conventional optimization method (one factor at a time) is well-studied. However, it has some drawbacks, such as the necessity of more experiments, the need to spend more time, and the inability to illuminate the synergistic effect of the variables. Optimization studies are increasingly utilizing response surface methodology (RSM) because it provides details about the interaction effects of variables with fewer experiments. This review discusses the application of RSM for bioleaching experiments from other solid wastes. It discusses the Central Composite and Box-Behnken designs as the most commonly used designs for optimizing bioleaching methods. The most influential factors for increasing the heavy metal recovery rate in applying RSM using the bioleaching process are recognized, and some suggestions are made for future research.

Identifiers

PMID37555097
PMCPMC10404936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.